How The Pandemic Changed FDA Inspections
The coronavirus pandemic forced the U.S. Food and Drug Administration to embrace new evaluation tools to assess compliance with current good manufacturing practice, or cGMP, regulations by FDA-regulated companies. These evaluation tools...To view the full article, register now.
Already a subscriber? Click here to view full article